• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory & Compliance
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Special Content
    • Special Reports
    • In-Depth Coverage
    • DeviceTalks
  • Podcasts
    • MassDevice Fast Five
    • DeviceTalks Weekly
    • OEM Talks
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Resources
    • About MassDevice
    • DeviceTalks
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices
Home » The year of the medtech mega-merger

The year of the medtech mega-merger

March 26, 2015 By Brad Perriello

The year of the medtech mega-merger

Source: EP Vantage.
Click image to enlarge.

The $40 billion worth of mergers and acquisitions last year in the medical device industry made it the year of the mega-merger, according to EP Vantage, with deal value more than doubling compared with 2013.

And that’s not even counting the largest merger in medtech history, Medtronic‘s (NYSE:MDT) $50 billion acquisition of Covidien, which closed in late January.

The number of initial public offerings also spiked in 2014, according to EP Vantage, the editorial arm of market intelligence firm Evaluate. There were 34 IPOs worth a collective $2.2 billion in the medical device space last year, nearly triple the amount raised the year before, according to the EP Vantage report, "Medtech 2014 in Review."

Some 7 of the 10 largest deals were worth more than $1 billion, according to the report, a sign of large-cap medtech players’ appetite for consolidation. That’s driven by the need to cut costs as pricing pressures mount from their hospital customers, according to EP Vantage.

But the focus on large buys means fewer of the small acquisitions that convince venture capitalists to back smaller firms, which in turn drive innovation in the industry, according to the report.

"There is a danger that startups might be unable to find cash, strangling potentially life-changing inventions before their development even truly begins," according to EP Vantage.

"Following the sombre days of 2013, last year saw the industry enjoy a resurgence in the merger and IPO markets, a near-doubling in FDA approvals of innovative devices and soaring company valuations on the public markets," author Elizabeth Cairns said in prepared remarks. "However, the trend towards company consolidation was not universally good news as it was partly driven by increased pricing pressures. The string of mega-mergers also shifted the focus away from smaller acquisitions, denying investors a key source of short-term returns."

Filed Under: Mergers & Acquisitions, News Well Tagged With: EP Vantage, Evaluate Ltd.

More recent news

  • Omnipod 5 rollout for type 2 rolls on as Insulet pursues next-gen automation
  • Ancora Heart reaches enrollment milestone in pivotal heart failure device trial
  • PharmaSens, SiBionics innovatively combine tech in all-in-one insulin patch pump
  • Johnson & Johnson launches daily disposable multifocal toric contact lens
  • Study backs Biolinq intradermal sensor in muscle loss prevention during GLP-1 therapy

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >

MEDTECH 100 Stock INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy